97 related articles for article (PubMed ID: 21477573)
1. Comment to the article: infliximab for treating sarcoidosis patients, Portuguese experience.
Morais A
Rev Port Pneumol; 2011; 17(2):94-5. PubMed ID: 21477573
[No Abstract] [Full Text] [Related]
2. Infliximab for treating sarcoidosis patients, Portuguese experience.
Aguiar M; Marçal N; Mendes AC; Bugalho de Almeida A
Rev Port Pneumol; 2011; 17(2):85-93. PubMed ID: 21477572
[TBL] [Abstract][Full Text] [Related]
3. Infliximab in sarcoidosis: more answers or more questions?
White ES
Am J Respir Crit Care Med; 2006 Oct; 174(7):732-3. PubMed ID: 16988163
[No Abstract] [Full Text] [Related]
4. Pulmonary sarcoidosis.
Baughman RP
Clin Chest Med; 2004 Sep; 25(3):521-30, vi. PubMed ID: 15331189
[TBL] [Abstract][Full Text] [Related]
5. [Successful treatment with infliximab of a patient with refractory sarcoidosis].
Fouchier SM; Möller GM; Van Santen-Hoeufft M; Faber CG; Smeenk FW; Drent M
Ned Tijdschr Geneeskd; 2004 Dec; 148(49):2446-50. PubMed ID: 15626311
[TBL] [Abstract][Full Text] [Related]
6. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement.
Baughman RP; Drent M; Kavuru M; Judson MA; Costabel U; du Bois R; Albera C; Brutsche M; Davis G; Donohue JF; Müller-Quernheim J; Schlenker-Herceg R; Flavin S; Lo KH; Oemar B; Barnathan ES;
Am J Respir Crit Care Med; 2006 Oct; 174(7):795-802. PubMed ID: 16840744
[TBL] [Abstract][Full Text] [Related]
7. Up-to-date in pulmonary and extrapulmonary sarcoidosis.
Valeyre D; Uzunhan Y; Bouvry D; Naccache JM; Nunes H
Acta Clin Belg; 2008; 63(6):408-13. PubMed ID: 19170359
[TBL] [Abstract][Full Text] [Related]
8. Long term follow-up of infliximab efficacy in pulmonary and extra-pulmonary sarcoidosis refractory to conventional therapy.
Russell E; Luk F; Manocha S; Ho T; O'Connor C; Hussain H
Semin Arthritis Rheum; 2013 Aug; 43(1):119-24. PubMed ID: 23332903
[TBL] [Abstract][Full Text] [Related]
9. The use of infliximab in cutaneous sarcoidosis.
Meyerle JH; Shorr A
J Drugs Dermatol; 2003 Aug; 2(4):413-4. PubMed ID: 12884466
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-alpha antagonist-induced sarcoidosis.
Clementine RR; Lyman J; Zakem J; Mallepalli J; Lindsey S; Quinet R
J Clin Rheumatol; 2010 Sep; 16(6):274-9. PubMed ID: 20808167
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary sarcoidosis in a patient with psoriatic arthritis during infliximab therapy.
Izzi S; Francesconi F; Visca P; Altieri A; De Mutiis C; Trevisan G; Bonifati C
Dermatol Online J; 2010 May; 16(5):16. PubMed ID: 20492833
[TBL] [Abstract][Full Text] [Related]
12. [Infliximab treatment for chronic sarcoidosis--a case series].
Jounieaux F; Chapelon C; Valeyre D; Israel Biet D; Cottin V; Tazi A; Fournier E; Wallaert B;
Rev Mal Respir; 2010 Sep; 27(7):685-92. PubMed ID: 20863968
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory profile and response to anti-tumor necrosis factor therapy in patients with chronic pulmonary sarcoidosis.
Loza MJ; Brodmerkel C; Du Bois RM; Judson MA; Costabel U; Drent M; Kavuru M; Flavin S; Lo KH; Barnathan ES; Baughman RP
Clin Vaccine Immunol; 2011 Jun; 18(6):931-9. PubMed ID: 21508170
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor alpha blockade as therapy for sarcoidosis: comment on the article by Ulbricht et al.
Lee AS; Utz JP; Specks U
Arthritis Rheum; 2004 Aug; 50(8):2717-8; author reply 2718-9. PubMed ID: 15334498
[No Abstract] [Full Text] [Related]
15. Infliximab therapy in pulmonary sarcoidosis.
Kähler CM; Heininger P; Loeffler-Ragg J; Vogelsinger H
Am J Respir Crit Care Med; 2007 Aug; 176(4):417; author reply 417-8. PubMed ID: 17675452
[No Abstract] [Full Text] [Related]
16. [Anti-TNF: beneficial or hamful for the lung?].
Tritar F; Zendah I; Ben M'rad S; Daghfous H
Tunis Med; 2009 Sep; 87(9):607-9. PubMed ID: 20180383
[TBL] [Abstract][Full Text] [Related]
17. Cytokine modulators in the treatment of sarcoidosis.
Bargagli E; Olivieri C; Rottoli P
Rheumatol Int; 2011 Dec; 31(12):1539-44. PubMed ID: 21644041
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of adalimumab in chronically active and symptomatic patients with sarcoidosis.
Kamphuis LS; Lam-Tse WK; Dik WA; van Daele PL; van Biezen P; Kwekkeboom DJ; Kuijpers RW; Hooijkaas H; van Laar JA; Bastiaans J; Baarsma GS; van Hagen PM
Am J Respir Crit Care Med; 2011 Nov; 184(10):1214-6. PubMed ID: 22086995
[No Abstract] [Full Text] [Related]
19. The potential additional benefit of infliximab in patients with chronic pulmonary sarcoidosis already receiving corticosteroids: a retrospective analysis from a randomized clinical trial.
Judson MA; Baughman RP; Costabel U; Mack M; Barnathan ES
Respir Med; 2014 Jan; 108(1):189-94. PubMed ID: 24361164
[TBL] [Abstract][Full Text] [Related]
20. New treatment strategies for pulmonary sarcoidosis: antimetabolites, biological drugs, and other treatment approaches.
Baughman RP; Grutters JC
Lancet Respir Med; 2015 Oct; 3(10):813-22. PubMed ID: 26204816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
